Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) EPS (Basic) (2020 - 2025)

Historic EPS (Basic) for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to -$0.62.

  • Biofrontera's EPS (Basic) rose 3673.47% to -$0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.49, marking a year-over-year decrease of 33281.25%. This contributed to the annual value of -$3.22 for FY2024, which is 7527.38% up from last year.
  • As of Q3 2025, Biofrontera's EPS (Basic) stood at -$0.62, which was up 3673.47% from -$0.57 recorded in Q2 2025.
  • Biofrontera's 5-year EPS (Basic) high stood at $4.55 for Q4 2023, and its period low was -$7.23 during Q2 2023.
  • Its 5-year average for EPS (Basic) is -$1.51, with a median of -$0.9 in 2022.
  • Within the past 5 years, the most significant YoY rise in Biofrontera's EPS (Basic) was 26250.0% (2023), while the steepest drop was 179748.73% (2023).
  • Biofrontera's EPS (Basic) (Quarter) stood at -$1.38 in 2021, then crashed by 102.9% to -$2.8 in 2022, then soared by 262.5% to $4.55 in 2023, then plummeted by 105.56% to -$0.25 in 2024, then crashed by 144.99% to -$0.62 in 2025.
  • Its EPS (Basic) was -$0.62 in Q3 2025, compared to -$0.57 in Q2 2025 and -$0.47 in Q1 2025.